Article
A prospective study to assess the impact of a novel CFTR therapy combination on body composition in patients with cystic fibrosis with F508del mutation.
Clinical nutrition (Edinburgh, Scotland) - 1 Dec 2023
Knott-Torcal Carolina, Sebastián-Valles Fernando, Girón Moreno Rosa María, Martín-Adán José Carlos, Jiménez-Díaz Jessica, Marazuela Mónica, Sánchez de la Blanca Nuria, Fernández-Contreras Raúl, Arranz-Martín Alfonso
Abstract excerpt
BACKGROUND & AIM: Malnutrition is a prevalent condition in Cystic Fibrosis (CF) and can result in worsening of pulmonary function and other comorbidities. Cystic fibrosis transmembrane regulator (CFTR) modulator therapies are improving the CF-related care and outcomes. Body Mass Index (BMI) is the most commonly used parameter to assess nutritional status, albeit it is a very unspecific indicator. Hence, current...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.